DoW Bone Marrow Failure, Investigator-Initiated Research Award

The DoW Bone Marrow Failure, Investigator-Initiated Research Award supports studies that further develop mature ideas, expand upon key discoveries, and have the potential to make significant advances in bone marrow failure research and/or patient care. This award mechanism allows for a partnering Principal Investigator and requires preliminary data relevant to the proposed project. Applications can support clinical research studies, but this mechanism does not allow clinical trials. The award provides an estimated funding of $1,250,000. • The award supports translational and clinical research, including studies in preclinical models, research with human data and/or anatomical substances, and research with human subjects. • The award mechanism does not support clinical trials, but may support Investigational New Drug (IND)-enabling efforts. • A partnering Principal Investigator is allowed, and both PIs will need to submit full applications. • Preliminary data relevant to the proposed project is required.